Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease

Neuroscience Letters

Volumn 401, Issue 3, 2006, Pages 203-208

  Mandrioli, Jessica ^a   Del Rio, Daniele ^b   Zini, Andrea ^a   Nichelli, Paolo ^a   Merelli, Elisa ^a   Beltrami, Diego ^b   Cesari, Catia ^b   Pellegrini, Nicoletta ^b   Brighenti, Furio ^b   Sola, Patrizia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Cerebrospinal fluid; Motor neuron disease; Oxidative stress; Total antioxidant capacity

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL DISEASE; MIGRAINE; MOTOR NEURON DISEASE; PRIORITY JOURNAL; TENSION HEADACHE;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE;

EID: 33646578473     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.03.013     Document Type: Article

References (43)

1. Abe K., Pan L.H., Watanabe M., Konno H., Kato T., and Hoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurosci. Lett. 19 (1997) 124-128
2. Alho H., Leinonen J.S., Erhola M., Lonnrot K., and Aejmelaeus R. Assay of antioxidant capacity of human plasma and CSF in aging and disease. Restor. Neurol. Neurosci. 12 (1998) 159-165
3. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 5 (2004) S18-S25
4. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., and Brown Jr. R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42 (1997) 644-654
5. Beal M.F. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J. Bioenerg. Biomembr. 36 (2004) 381-386
6. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239 (1996) 70-76
7. Block G., Dietrich M., Norkus E.P., Morrow J.D., Hudes M., Caan B., and Packer L. Factors associated with oxidative stress in human populations. Am. J. Epidemiol. 156 (2002) 274-285
8. Bogdanov M.B., Ramos L.E., Xu Z., and Beal M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71 (1998) 1321-1324
9. Bonnefont-Rousselot D., Lacomblez L., Jaudon M., Lepage S., Salachas F., Bensimon G., Bizard C., Doppler V., Delattre J., and Meininger V. Blood oxidative stress in amyotrophic lateral sclerosis. J. Neurol. Sci. 178 (2000) 57-62
10. Bowling A.C., Schulz J.B., Brown Jr. R.H., and Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61 (1993) 2322-2325
11. Bruijn L.I., Beal M.F., Becher M.W., Schulz J.B., Wong P.C., Price D.L., and Cleveland D.W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALSlinked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7606-7611
12. Cao G., Giovanoni M., and Prior R.L. Antioxidant capacity decreases during growth but not aging in rat serum and brain. Arch. Gerontol. Geriatr. 22 (1996) 27-37
13. Carrì M.T., Ferri A., Cozzolino M., Calabrese L., and Rotilio G. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res. Bull. 61 (2003) 365-374
14. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
15. Cluskey S., and Ramsden D.B. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol. Pathol. 54 (2001) 386-392
16. Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., and Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52 (2002) 448-457
17. De Bustos F., Jimenez-Jimenez F.J., Molina J.A., Esteban J., Guerrero-Sola A., Zurdo M., Orti-Pareja M., Tallon-Barranco A., Gomez-Escalonilla C., Ramirez- Ramos C., Arenas J., and Enriquez de Salamanca R. Cerebrospinal fluid levels of alphatocopherol in amyotrophic lateral sclerosis. J. Neural. Transm. 105 (1998) 703-708
18. Del Aguila M.A., Longstreth Jr. W.T., McGuire V., Koepsell T.D., and Van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60 (2003) 813-819
19. Donaghy M. Classification and clinical features of motor neuron diseases and motor neuropathies in adults. J. Neurol. 246 (1999) 331-333
20. Elsayed N.M. Antioxidant mobilization in response to oxidative stress: a dynamic environmental-nutritional interaction. Nutrition 10 (2001) 828-834
21. Emerit J., Edeas M., and Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58 (2004) 39-46
22. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown Jr. R.H., and Beal M.F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69 (1997) 2064-2074
23. Fitzmaurice P.S., Shaw I.C., Kleiner H.E., Miller R.T., Monks T.J., Lau S.S., Mitchell J.D., and Lynch P.G. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19 (1996) 797-798
24. Ghiselli A., Serafini M., Maiani G., Azzini E., and Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic. Biol. Med. 18 (1995) 29-36
25. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 (2001) 685-716
26. I. Hervias, M.F. Beal, G. Manfredi. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve. Early View (Articles online in advance of print) Published Online: 21 Dec 2005.
27. Ilzecka J. Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients. Scand J. Clin. Lab. Invest. 63 (2003) 297-302
28. Joseph J.A., Denisova N., Fisher D., Bickford P., Prior R., and Cao G. Age-related neurodegeneration and oxidative stress: putative nutritional intervention. Neurol. Clin. 16 (1998) 747-755
29. Kaufmann E., Boehm B.O., Süssmuth S.D., Kientsch-Engel R., Sperfeld A., Ludolph A.C., and Tumani H. The advanced glycation end-product Nε-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 371 (2004) 226-229
30. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5 (1999) 347-350
31. Lonnrot K., Metsa-Ketela T., Molnar G., Ahonen J.P., Latvala M., Peltola J., Pietila T., and Alho H. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic. Biol. Med. 21 (1996) 211-217
32. Manfredi G., and Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5 (2005) 77-87
33. Menzies F.M., Ince P.G., and Shaw P.J. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem. Int. 40 (2002) 543-551
34. Miller R.G., Mitchell J.D., and Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph. Lateral. Scler. Other Motor. Neuron. Disord. 4 (2003) 191-206
35. Moreira P.I., Siedlak S.L., Aliev G., Zhu X., Cash A.D., Smith M.A., and Perry G. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J. Neural. Transm. 112 (2005) 921-932
36. Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.F., Crow J.P., Cashman N.R., Kondejewski L.H., and Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277 (2002) 47551-47556
37. Serafini M., and Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?. Redox Rep. 9 (2004) 145-152
38. Shaw P.J., Ince P.G., Falkous G., and Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 38 (1995) 691-695
39. Simpson E.P., Yen A.A., and Appel S.H. Oxidative stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr. Opin. Rheumatol. 15 (2003) 730-736
40. Singh P., Mann K.A., Mangat H.K., and Kaur G. Prolonged glutamate excitotoxicity: effects on mitochondrial antioxidants and antioxidant enzymes. Mol. Cell. Biochem. 243 (2003) 139-145
41. Trevisan M., Browne R., Ram M., Muti P., Freudenheim J., Carosella A.M., and Armstrong D. Correlates of markers of oxidative status in the general population. Am. J. Epidemiol. 154 (2001) 348-356
42. Vielhaber S., Kunz D., Winkler K., Wiedemann F.R., Kirches E., Feistner H., Heinze H.J., Elger C.E., Schubert W., and Kunz W.S. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123 (2000) 1339-1348
43. World Federation of Neurology Research Group on Motor Neuron Diseases - El Escorial revised criteria for the diagnosis of amyotrophic lateral sclerosis. Available at http://www.wfnals.org/guidelines/1998elescorial/elescorial1998.htm, accessed April 2005.